{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:58:31Z","timestamp":1780876711896,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["23K15491"],"award-info":[{"award-number":["23K15491"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48913-5","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:04:33Z","timestamp":1776254673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RAGE signaling inhibition prevents the malignant phenotypes of pancreatic ductal adenocarcinoma cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Hironori","family":"Minami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Munesue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Tokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nakanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"48913_CR1","unstructured":"World Health Organization. Pancreas & Source, G. (2022). https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/13-pancreas-fact-sheet.pdf, [accessed June 6, 2024]."},{"issue":"1","key":"48913_CR2","doi-asserted-by":"publisher","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson, H. M., Chandana, S., Wright, G. P. & Chung, M. Pancreatic Cancer: A review of current treatment and novel therapies. J. Invest. Surg. 36 (1), 2129884 (2023).","journal-title":"J. Invest. Surg."},{"key":"48913_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman, M. H. & Beatty, G. L. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu. Rev. Pathol. 18, 123\u2013148 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"48913_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00105","volume":"4","author":"Y Yamamoto","year":"2013","unstructured":"Yamamoto, Y. & Yamamoto, H. RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication. Front. Endocrinol. (Lausanne) 4, 105 (2013).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"48913_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/pros.20219","volume":"64","author":"H Ishiguro","year":"2005","unstructured":"Ishiguro, H. et al. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 64, 92\u2013100 (2005).","journal-title":"Prostate"},{"key":"48913_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0002-9440(10)62296-1","volume":"166","author":"H Kuniyasu","year":"2005","unstructured":"Kuniyasu, H. et al. Colon cancer cell-derived high mobility group 1\/amphoterin induces growth inhibition and apoptosis in macrophages. Am. J. Pathol. 166, 751\u2013760 (2005).","journal-title":"Am. J. Pathol."},{"key":"48913_CR7","first-page":"928","volume":"51","author":"M Takada","year":"2004","unstructured":"Takada, M., Hirata, K., Ajiki, T., Suzuki, Y. & Kuroda, Y. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 51, 928\u2013930 (2004).","journal-title":"Hepatogastroenterology"},{"key":"48913_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep22450","volume":"6","author":"MB Manigrasso","year":"2016","unstructured":"Manigrasso, M. B. et al. Small molecule inhibition of ligand-stimulated RAGE-DIAPH1 signal transduction. Sci. Rep. 6, 22450 (2016).","journal-title":"Sci. Rep."},{"key":"48913_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1091\/mbc.E17-07-0460","volume":"29","author":"NG Dulyaninova","year":"2018","unstructured":"Dulyaninova, N. G., Ruiz, P. D., Gamble, M. J., Backer, J. M. & Bresnick, A. R. S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol. Biol. Cell 29, 632\u2013642 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"48913_CR10","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/S0959-8049(03)00490-8","volume":"39","author":"M D\u2019Incalci","year":"2003","unstructured":"D\u2019Incalci, M. et al. The combination of yondelis and cisplatin is synergistic against human tumor xenografts.. Eur. J. Cancer 39, 1920\u20131926 (2003).","journal-title":"Eur. J. Cancer"},{"key":"48913_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2014.09.019","volume":"355","author":"M Okazaki","year":"2014","unstructured":"Okazaki, M. et al. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.. Cancer Lett. 355, 46\u201353 (2014).","journal-title":"Cancer Lett."},{"key":"48913_CR12","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/cncr.22731","volume":"109","author":"A Takeuchi","year":"2007","unstructured":"Takeuchi, A. et al. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.. Cancer 109, 2532\u20132540 (2007).","journal-title":"Cancer"},{"key":"48913_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/07357900701560521","volume":"25","author":"Y Murakami","year":"2007","unstructured":"Murakami, Y. et al. Receptor for advanced glycation end products (RAGE) -soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.. Cancer Invest. 25, 720\u2013725 (2007).","journal-title":"Cancer Invest."},{"key":"48913_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/35012626","volume":"405","author":"P Tesarov\u00e1","year":"2000","unstructured":"Tesarov\u00e1, P. et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.. Nature 405, 354\u2013360 (2000).","journal-title":"Nature"},{"key":"48913_CR15","first-page":"4805","volume":"62","author":"HJ Huttunen","year":"2002","unstructured":"Huttunen, H. J., Fages, C., Kuja-Panula, J., Ridley, A. J. & Rauvala, H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.. Cancer 62, 4805\u20134811 (2002).","journal-title":"Cancer"},{"key":"48913_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-007-9488-y","volume":"87","author":"R Bassi","year":"2008","unstructured":"Bassi, R. HMGBI as an autocrine stimulus in human T98G glioblastoma cells: Role in cell growth and migration.. J. Neurooncol. 87, 23\u201333 (2008).","journal-title":"J. Neurooncol."},{"key":"48913_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11605-011-1754-9","volume":"16","author":"J DiNorcia","year":"2012","unstructured":"DiNorcia, J. et al. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. J. Gastrointest. Surg. 16, 104\u2013112 (2012). discussion 12.","journal-title":"J. Gastrointest. Surg."},{"key":"48913_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14283\/jpad.2018.18","volume":"5","author":"AH Burstein","year":"2018","unstructured":"Burstein, A. H. et al. Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer\u2019s disease. J. Prev. Alzheimers Dis. 5, 149\u2013154 (2018).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"48913_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid \u03b2-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122, 1377\u20131392 (2012).","journal-title":"J. Clin. Invest."},{"key":"48913_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/cas.12133","volume":"104","author":"A Takeuchi","year":"2013","unstructured":"Takeuchi, A. et al. Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells. Cancer Sci. 104, 740\u2013749 (2013).","journal-title":"Cancer Sci."},{"key":"48913_CR21","first-page":"4627","volume":"15","author":"AHAM El-Far","year":"2018","unstructured":"El-Far, A. H. A. M. In vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system. Oncol. Lett. 15, 4627\u20134634 (2018).","journal-title":"Oncol. Lett."},{"key":"48913_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00595-016-1426-1","volume":"47","author":"Y Watanabe","year":"2017","unstructured":"Watanabe, Y. et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: A retrospective review. Surg. Today 47, 555\u2013567 (2017).","journal-title":"Surg. Today"},{"key":"48913_CR23","doi-asserted-by":"publisher","first-page":"11119","DOI":"10.18632\/oncotarget.24264","volume":"9","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi, K. et al. Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models. Oncotarget 9, 11119\u201311125 (2018).","journal-title":"Oncotarget"},{"key":"48913_CR24","first-page":"901","volume":"13","author":"X Fu","year":"1993","unstructured":"Fu, X., Le, P. & Hoffman, R. M. A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer. Anticancer Res. 13, 901\u2013904 (1993).","journal-title":"Anticancer Res."},{"key":"48913_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jso.23507","volume":"109","author":"CA Metildi","year":"2014","unstructured":"Metildi, C. A. et al. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J. Surg. Oncol. 109, 451\u2013458 (2014).","journal-title":"J. Surg. Oncol."},{"key":"48913_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.2910530414","volume":"53","author":"T Furukawa","year":"1993","unstructured":"Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M. & Hoffman, R. M. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: Correlation of metastatic sites in mouse and individual patient donors. Int. J. Cancer 53, 608\u2013612 (1993).","journal-title":"Int. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48913-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48913-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48913-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:22:49Z","timestamp":1780874569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48913-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48913"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48913-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7453288\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"I certify that all my affiliations or financial involvement with any organization or financial conflict with the subject matter discussed in the manuscript are completely disclosed in the acknowledgement section of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"17617"}}